Almanack Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,258
Closed -$279K 163
2023
Q2
$279K Sell
1,258
-4
-0.3% -$928 0.05% 136
2023
Q1
$305K Sell
1,262
-40
-3% -$9.82K 0.06% 129
2022
Q4
$342K Sell
1,302
-600
-32% -$161K 0.07% 114
2022
Q3
$429K Sell
1,902
-3,074
-62% -$745K 0.08% 87
2022
Q2
$1.21M Buy
4,976
+1,375
+38% +$337K 0.12% 122
2022
Q1
$871K Buy
3,601
+1,024
+40% +$235K 0.08% 169
2021
Q4
$580K Sell
2,577
-9
-0.3% -$1.9K 0.05% 234
2021
Q3
$550K Buy
2,586
+161
+7% +$37.1K 0.05% 241
2021
Q2
$591K Sell
2,425
-1,660
-41% -$408K 0.06% 197
2021
Q1
$1.02M Buy
4,085
+487
+14% +$116K 0.1% 132
2020
Q4
$827K Buy
3,598
+580
+19% +$134K 0.09% 136
2020
Q3
$729K Buy
3,018
+598
+25% +$148K 0.09% 149
2020
Q2
$571K Buy
2,420
+1,147
+90% +$262K 0.1% 112
2020
Q1
$258K Buy
1,273
+415
+48% +$90.6K 0.06% 197
2019
Q4
$207K Buy
+858
New +$189K 0.04% 186
2019
Q3
Sell
-863
Closed -$159K 238
2019
Q2
$159K Buy
+863
New +$155K 0.04% 204
2019
Q1
Sell
-1,481
Closed -$288K 147
2018
Q4
$288K Buy
1,481
+34
+2% +$6.63K 0.09% 118
2018
Q3
$286K Buy
+1,447
New +$285K 0.08% 135
2017
Q3
Sell
-971
Closed -$167K 151
2017
Q2
$167K Buy
+971
New +$158K 0.09% 125

Other funds holding AMGN

Almanack Investment Partners's AMGN Position: Q3 2023 in Review

Almanack Investment Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,258 shares — an estimated $279K sold.

Almanack Investment Partners first reported a position in AMGN in Q2 2017 and held it in 19 quarters. The position peaked at $1.21M in Q2 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Almanack Investment Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Almanack Investment Partners sold 1,258 Amgen shares in Q3 2023, an estimated $279K.
  • Almanack Investment Partners first reported a position in Amgen in Q2 2017 and held it in 19 quarters.
  • Almanack Investment Partners's Amgen position peaked at $1.21M in Q2 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Almanack Investment Partners's 13F filing for Q3 2023, filed 5 Oct 2023.